Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CAR-T > CD19 > CHEK-ATS056

HEK293/Human Anti-CD19 Stable Cell Line

  • Description

    HEK293/Human Anti-CD19 Stable Cell Line

  • Application

    Binding assay by FACS and cell based ELISA

  • Growth Properties

    Adherent

  • Selection Marker

    Puromycin (5 μg/mL)

  • Culture Medium

    DMEM medium + 10% FBS

  • Freeze Medium

    10% DMSO + 90% FBS

  • Format/Supplied As

    1 vial contains at least 5x10^6 cells in 1 ml of 10% DMSO in FBS.

  • Storage

    Frozen in liquid nitrogen

  • Instructions for Use

    See data sheet for detailed culturing protocol

Receptor Assay
Receptor Assay

FACS assay shows that PE-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 can bind to HEK293/Human Anti-CD19 Stable Cell Line. HEK293/Human Anti-CD19 Stable Cell Line was red line, Negative control HEK293 cells was grey line(QC tested).

Receptor Assay

FACS assay shows that PE-Labeled Human CD19 (20-291), His Tag can bind to HEK293/Human Anti-CD19 Stable Cell Line. HEK293/Human Anti-CD19 Stable Cell Line was red line, Negative control HEK293 cells was grey line(QC tested).

  • Background
    Chimeric antigen receptors (CARs) comprise interact domains, of which target cancer cell expressed antigens and allow T cell to efficiently kill the cancer cell. FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. Our CAR-like cells apply the HEK293 cells for the expression of FMC63 which will be presented on the cell membrane. It mimics the real CAR-T cell reaction and it is used as positive control for Anti-CD19 scFv Antibody flow cytometry detection.
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Comments (0)

Price(USD) : $6900.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:9 Details
  • Number of Drugs in Clinical Trials:181 Details
  • Latest Research Phase:Phase 3 Clinical

Datasheet & Documentation

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message